Advertisement

Multiple mechanisms of immunologic tolerance: Novel approaches for unresponsiveness

  • David W. Scott
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 386)

Abstract

I mmunologic tolerance is defined as a specific unresponsive state induced by prior exposure to an antigen or antigenic determinant. It is now clear that tolerance can be induced in both immature and mature lymphocytes of the T- or B-cell lineages. The mechanisms involved appear to be multiple: anergy (that is, the failure to respond to specific signaling), deletion of specific clones (via apoptosis), or suppression of reactivity, all of which may exist in the same organism depending on the antigen. Procedures to facilitate tolerance induction in adults who have made undesirable immune responses (for example, to blood products or red-cell antigens) will require novel approaches. We report here on data supporting a deletional mechanism by apoptosis in both neoplastic and normal murine B cells, and further describe protocols for the induction and maintenance of unresponsiveness in T- and B-lymphocyte clones in adult hosts.

Keywords

Major Histocompatibility Complex Class Tyrosine Phosphorylation Myelin Basic Protein Growth Arrest Tolerance Induction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    M. Venkataraman, and D.W. Scott, Cellular events in tolerance. VII. Decrease in tolerance spleens of clonable precursors stimulatable in vitro by specific antigens or LPS. Cell. Immunol 47: 323 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    GJ.V. Nossal, and B. Pike, Mechanisms of clonal abortion tolerogenesis. II. Clonal behavior of immature B cells following exposure to anti-p. chain antibody. Immunology . 37: 203 (1979).PubMedGoogle Scholar
  3. 3.
    G.L. Warner, and D.W. Scott, A polyclonal model for B-cell tolerance. I. Fc-dependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig. J. Immunol 146: 2185 (1991).PubMedGoogle Scholar
  4. 4.
    R. Carsetti, G. Köhler, and M.C. Lamers, A role for immunoglobulin D: Interference with tolerance induction. Eur. J. Immunol. 23: 168 (1993).PubMedCrossRefGoogle Scholar
  5. 5.
    D.W. Scott, D. Livnat, CA. Penneil, and P. Keng, Lymphoma models for B-cell activation and tolerance III. Cell cycle dependence for negative signaling of WEHI-231 B lymphoma cells by anti-µ. J. Exp. Med. 164: 156 (1986).PubMedCrossRefGoogle Scholar
  6. 6.
    D.W. Scott, B-lymphoma models for tolerance: The good, the bad, and the apoptotic. ImmunoMethods . 2: 105 (1993).CrossRefGoogle Scholar
  7. 7.
    J. Hasbold and G.G.B. Klaus, Anti-immunoglobulin antibodies induce apoptosis in immature B-cell lymphomas. Eur. J. Immunol 20: 1685 (1990).PubMedCrossRefGoogle Scholar
  8. 8.
    L. Benhamou, P. Casenave, and P. Sarthou, Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 20: 1405 (1990).PubMedCrossRefGoogle Scholar
  9. 9.
    J. Cambier, J. Monroe, M. Coggeshall, and K. Campbell, The biochemical basis of transmembrane signaling by B lymphocyte surface immunoglobulin. Immunol Today . 6: 218 (1985).CrossRefGoogle Scholar
  10. 10.
    M. Coggeshall, and J. Cambier, B-cell activation VIII. Membrane immunoglobulins transduce signals via activation of phosphatidylinositol hydrolysis. J. Immunol 133: 3382 (1984).PubMedGoogle Scholar
  11. 11.
    G.G.B. Klaus, M. Bijsterbosch, A. O’Garra, M. Harnett, and K. Rigley, Receptor signaling and crosstalk in B lymphocytes. Immunol Rev . 99: 19 (1987).PubMedCrossRefGoogle Scholar
  12. 12.
    J. Imboden, The regulation of intracellular signals during lymphocyte activation. Immunol Today . 9: 17 (1988).PubMedCrossRefGoogle Scholar
  13. 13.
    J. Cambier, and K. Campbell, Membrane immunoglobulin and its accomplices: New lessons from an old receptor. FASEB J . 6: 3207 (1992).PubMedGoogle Scholar
  14. 14.
    M.-A. Campbell, and B.M. Sefton, Association between B-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinase mRNA expression. Molec. and Cell Biol 12: 2315 (1992).Google Scholar
  15. 15.
    L.R. Bandara, J.P. Adamczewski, T. Hunt, and N. La Thangue, Cyclin-A and the retinoblastoma gene product complex with a common transcription factor. Nature . 352: 249 (1991).PubMedCrossRefGoogle Scholar
  16. 16.
    J. Milner, A. Cook, and J. Mason, p53 is associated with p34cdc2 in transformed cells. EMBO J . 9: 2885 (1990).PubMedGoogle Scholar
  17. 17.
    M. Beckwith, W. Urba, D. Ferris, D. Kuhns, C. Moratz, and D. Longo, Anti-Ig-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation. J. Immunol 147: 2411 (1991).PubMedGoogle Scholar
  18. 18.
    X-r. Yao, and D.W. Scott, Expression of protein tyrosine kinases in the Ig complex of anti-u-sensitive and anti-p -resistant B-cell lymphomas: Role of the p55blk kinase in signaling growth arrest and apoptosis. Immunol Rev . 132: 163 (1993).CrossRefGoogle Scholar
  19. 19.
    X-r. Yao, and D.W. Scott, Antisense oligonucleotides to the blk tyrosine kinase prevent anti-u-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc. Nat’l Acad. Sci. USA. 90: 7946 (1993).CrossRefGoogle Scholar
  20. 20.
    J-E. Alés-Martínez, G. Warner, and D.W. Scott, Immunoglobulin D and M mediate signals that are qualitively different in B cells with an immature phenotype. Proc. Nat’l. Acad. Sci. USA. 85: 6919 (1988).CrossRefGoogle Scholar
  21. 21.
    . R. Tisch, C. Roifman, and N. Hozumi, Functional differences between immunoglobu¬lins M and D expressed on the surface of an immature B-cell line. Proc. Nati. Acad. Sci.USA. 85: 6914 (1988).CrossRefGoogle Scholar
  22. 22.
    A. Burkhardt, M. Brunswick, J. Bolen, and J. Mond, Anti-immunoglobulin stimulation of B lymphocytes activates x/r-related protein-tyrosine kinase. Proc. Nat’l. Acad. Sci. USA. 88: 7410 (1991).CrossRefGoogle Scholar
  23. 23.
    D. Hata, T. Kawakami, T. Ishigami, K.-M. Kim, T. Heike, K. Katamura, M. Mayumi, and H. Mikawa, Tyrosine phosphorylation of IgM and IgD-associated molecules of a human B lymphoma cell line B104. Int. Immunol 4: 797 (1992).PubMedCrossRefGoogle Scholar
  24. 24.
    M. Brunswick, A. Burkhardt, F. Finkelman, J. Bolen, and J. Mond, Comparison of tyrosine kinase activation by mitogenic and nonmitogenic anti-IgD antibodies. J. Immunol 149: 2249 (1992).PubMedGoogle Scholar
  25. 25.
    J.-E. Alés-Martínez, E. Cuende, J. Casnellie, R.P. Phipps, G. Warner, and D.W. Scott, Crosslinking of surface IgM and IgD causes differential biological effects in spite of overlap of tyrosine (de)phosphorylation profiles. Eur. J. Immunol 22: 845 (1992).PubMedCrossRefGoogle Scholar
  26. 26.
    K.-M. Kim, T. Yoshimura, H. Watanabe, T. Ishigimi, M. Nambu, D. Hata, Y. Higaki, M. Sasaki, T. Tsutsui, M. Mayumi, and H. Mikawa, Growth regulation of a human mature B-cell line, B-104, by anti-IgM and anti-IgD antibodies, J. Immunol 146: 819 (1991).Google Scholar
  27. 27.
    P. Mongini, C. Blessinger, D. Posnett, and S. Rudich, Membrane IgD and membrane IgM differs in capacity to transduce inhibitory signals with the same human B-cell clonal populations, J. Immunol 143: 1565 (1989).PubMedGoogle Scholar
  28. 28.
    S. Mittnacht, and R.A. Weinberg, Gl/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell . 65: 381 (1991).PubMedCrossRefGoogle Scholar
  29. 29.
    G. Draetta, Cell cycle control in eucaryotes molecular mechanisms of cdc2 activation. Trends Biochem . 15: 378 (1990).CrossRefGoogle Scholar
  30. 30.
    T. Hunter, and J. Pines, Cyclins and cancer. Cell 66: 1071 (1991).PubMedCrossRefGoogle Scholar
  31. 31.
    J.E. McCormack, V.H. Pepe, B.R. Kent, M. Dean, A. Marshak-Rothstein, and G. Sonenshein, Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma line. Proc. Nat’l. Acad. Sci. USA. 81: 5546 (1984).CrossRefGoogle Scholar
  32. 32.
    V. Seyfert, V. Sukhatme, and J. Monroe, Differential expression of a zinc finger-encoding gene in response to positive vs. negative signaling through receptor immunoglobulin in murine B lymphocytes. Mol Cell. Biol 9: 2083 (1989).PubMedGoogle Scholar
  33. . G.L. Warner, D. Nelson, A. Gaur, J. Ludlow, and D.W. Scott, Anti-Ig induces TGF-ß and pRB hypophosphorylation in a model for B-cell tolerance. Cell Growth and Differentiation 3: 175 (1992).Google Scholar
  34. 34.
    S.M. Mashesaran, J.E. McCormick, and G. Sonenshein, Changes in phosphorylation of myc oncogene and RB anti-oncogene protein products during growth arrest of the murine lymphoma WEHI-231 cell line. Oncogene . 6: 1965 (1992).Google Scholar
  35. 35.
    C.A. Spencer, and M. Groudine, Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56: 1 (1991).PubMedCrossRefGoogle Scholar
  36. 36.
    R. Hekkila, G. Schwab, E. Wickstrom, S.L. Loke, D. Pluznik, R. Watt, and L.N. Neckers, A c-myc antisense oligonucleotide inhibits entry into S phase, but not progress for GO to Gl. Nature . 328: 445 (1987).CrossRefGoogle Scholar
  37. 37.
    E.M. Blackwood, and R.N. Eisenman, A helix-loop-helix-zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science . 251: 1211 (1991).PubMedCrossRefGoogle Scholar
  38. 38.
    V. Sukhatme, S. Kartha, F. Toback, R. Taub, R. Hoover, and CA. Tsai-Morris, Novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res . 1: 343 (1987).PubMedGoogle Scholar
  39. 39.
    J. Monroe, Molecular basis for unresponsiveness and tolerance induction in immature stage B lymphocytes. Adv. Cell Molec. Immunol , 1b: 1 (1993).Google Scholar
  40. 40.
    V. Seyfert, S. McMahon, W. Glenn, A. Yellen, V. Sukhatme, X. Cao, and J. Monroe, Methylation of an immediate-early inducible gene as a mechanism for B-cell tolerance induction. Science . 250, 797 (1990).PubMedCrossRefGoogle Scholar
  41. 41.
    G. Evan, A. Wyllie, C. Gilbert, T. Littlewood, H. Land, M. Brooks, C. Waters, L Perm, and D. Hancock, Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119 (1992).PubMedCrossRefGoogle Scholar
  42. 42.
    Y. Shi, J. Glynn, L. Guilbert, T. Cotter, R. Bissonnette, and D. Green, Role for c-myc in activation-induced apoptotic cell death in T-cell hybridomas. Science . 257: 212 (1992).PubMedCrossRefGoogle Scholar
  43. 42.
    . Y. Shi, J. Glynn, L. Guilbert, T. Cotter, R. Bissonnette, and D. Green, Role for c-myc in activation-induced apoptotic cell death in T-cell hybridomas. Science . 257: 212 (1992).PubMedCrossRefGoogle Scholar
  44. 44.
    S. Roy, M. Scherer, TJ. Briner, J.A. Smith, and M.L. Center, Murine MHC polymorphism and T-cell specificites. Science . 244: 572 (1989).CrossRefGoogle Scholar
  45. 45.
    G. Ada, G. Nossal, J. Pye, and A. Abbot, Preparation and properties of flagellar antigens from Salmonella adelaide . Austral, J. Exp. Biol. Med. 42: 267 (1964).CrossRefGoogle Scholar
  46. 46.
    D.W. Scott, Role of self-carriers in the immune response and tolerance I. B-cell unresponsiveness and cytotoxic T-cell immunity induced by haptenated syngeneic lymphoid cells. J. Exp. Med 144: 69 (1976).PubMedCrossRefGoogle Scholar
  47. 47.
    M. Scherer, B. Chan, F. Ria, J. Smith, D. Perkins, and M. Gefter, Control of cellular and humoral immune responses by peptides containing T-cell epitopes. Cold Spring Harbor Symp. on Quantit. Biol. 54: 497 (1989).Google Scholar
  48. 48.
    D.M. Bitar, and C.C. Whitacre, Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell Immunol 112: 364 (1988).PubMedCrossRefGoogle Scholar
  49. 49.
    S.S. Zamvil, DJ. Mitchell, A.C. Moore, K. Kitamura, L Steinman, and J. Rothbard, T-cell epitope of the auto-antigen myelin basic protein that induces encephalomyelitis. Nature . 324: 258 (1986).PubMedCrossRefGoogle Scholar
  50. 50.
    A. Gaur, B. Wiers, A. Lin, J. Rothbard, and C.G. Fathman, Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science . 258: 1491 (1992).PubMedCrossRefGoogle Scholar
  51. 51.
    M. Bijsterbosch, and G.G.B. Klaus, Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J. Exp. Med 162: 1825 (1985).PubMedCrossRefGoogle Scholar
  52. 52.
    G.L. Warner, and D.W. Scott, A polyclonal model for B-cell tolerance I. Fc-dependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig. J. Immunol 146: 2185 (1991).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1995

Authors and Affiliations

  • David W. Scott
    • 1
  1. 1.University of Rochester Cancer Center and Department of Microbiology and ImmunologySchool of Medicine and DentistryRochesterUSA

Personalised recommendations